STUDY OF ENZYMURIA INDICATORS IN PATIENTS WITH RENAL DYSFUNCTION AND CHRONIC HEART FAILURE

Authors
  • Alikulov I.T.

    Tashkent State Medical University

    Author

  • Rustamova M. T.

    Tashkent State Medical University

    Author

Abstract

Chronic heart failure (CHF) is the most common, progressive, and unfavorable disease of the cardiovascular system, and is also the most frequent cause of patient hospitalization. According to the Framingham study, CHF incidence doubles every ten years. CHF significantly worsens patients' quality of life and increases the risk of death by up to 4 times. The annual mortality rate in patients can be 15-50%. The risk of sudden death in patients with CHF is 5 times higher than in those without chronic heart failure. The most common cause of CHF is ischemic heart disease (IHD), which accounts for 54-68.6% of patients with CHF (1,9). Myocardial infarction is one of the main causes of CHF development and is characterized by post-infarction remodeling of the left ventricle (LV): structural and functional restructuring of the LV and impairment of systolic and diastolic functions. CHF is one of the most important determinants in the development of chronic kidney disease (CKD). A number of retrospective studies have established that there is a correlation between the development of chronic heart failure (CHF) and renal dysfunction (RD), which leads to a deterioration in patients' lives (5,12). An increase in overall and cardiovascular mortality in CKD is observed even with a slight decrease in renal function and is especially pronounced in patients with cardiovascular diseases, including those with chronic heart failure (6,13). The results of epidemiological and population studies indicate that even subclinical impairment of renal function is an independent risk factor for cardiovascular complications (CVC) and mortality. It is evident that in CHF, the creatinine level is analogous to the ejection fraction and is an independent predictor of adverse outcomes (4,7). Patients with both CKD and CHF have a high risk of developing renal failure and require replacement therapy. The results of numerous epidemiological, prospective, retrospective, clinical, and specially planned studies show that severe renal dysfunction can cause various cardiovascular conditions, including myocardial infarction (MI), sudden death, cerebral ischemic stroke, and primary heart failure (10).

References

1.Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. – Хроническая сердечная недостаточность. Избранные лекции по кардиологии. – М.: ГЭОТАР–Медиа, 2006 -С. 432.

2.Камышников В.С. Справочник по клинико-биохимической лабораторной диагностике. – Беларусь: в 2 т. 2-е изд., 2002. – 463стр.

3. Мавлянов И.Р., Акбарова Г.П., Хабилова Н.Л. Состояние тубулоэпителиальной системы почек у больных ревматоидным артритом в зависимости от длительности заболевания. – В помощь практикующему врачу. Профилактическая медицина, 2009; 3: 14-19.

4. Национальные рекомендации ВНОК и Научного общества нефрологов России. Функциональное состояние почек и прогнозирование сердечно-сосудистого риска. – Москва: «Кардиоваскулярная терапия и профилактика», приложение 3, 2008, 7(6).

5. Резник Е.В. , Гендлин Г. Е., Сторожаков Г. И. Дисфункция почек у больных с хронической сердечной недостаточностью патогенез, диагностика и лечение. Ж. Сердечная недостаточность, 2005; 6: 45-50

6.Berl T., Henrich W. Kidney-Heart interactions: Epidemiology, pathogenesis, and treatment // Clin. J. Am. Soc. Nephrol. 2006; 1: 8-18.

7.Coca S.G., Yalavarthy R., Concato J., Parikh C.R. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review // Kidney International. 2008; 73(9): 1008-1016.

8.Eilers H., Liu K.D., Gruber A., Niemann C.U. Chronic kidney disease: implications for the perioperative period // Minerva Anestesiol. 2010; 76(9): 725-736.

9.Engelfriet P. M., Hoogenveen R. T., Boshuizen H. C., Baal van P. H. To die with of from heart failure: a difference that counts: is heart failure underrepresented in national mortality statistics? Eur J Heart Fail , 2011.vol. 13, pp. 377-38.

Downloads
Published
2026-04-13
Section
Articles
License
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

STUDY OF ENZYMURIA INDICATORS IN PATIENTS WITH RENAL DYSFUNCTION AND CHRONIC HEART FAILURE. (2026). Eureka Journal of Health Sciences & Medical Innovation, 2(4), 135-141. https://eurekaoa.com/index.php/5/article/view/783